BMAL1 and central nervous system cancer: An analysis on data from The Cancer Genome Atlas (TCGA) database showed an upregulation of BMAL1 in high-grade glioma patients,82 while BMAL1 was downregulated in patient-derived glioma stem cells (GSC) and impaired their progression.83